Evidence map›Paper›PMID 33004043›Full record

ArticleMicrobial cell factories2020

The temperature of growth and sporulation modulates the efficiency of spore-display in Bacillus subtilis.

Claudia Petrillo, Stefany Castaldi, Mariamichela Lanzilli, Anella Saggese, Giuliana Donadio, Loredana Baccigalupi, Ezio Ricca, Rachele Isticato

Abstract read
In one paragraph

Article in Microbial cell factories, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. The Bacterial Spore as a Mucosal Vaccine Delivery System.International journal of molecular sciences · 2023
    Review
  3. Review
  4. Computational and structural biotechnology journal · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Plant Growth Promotion Function ofInternational journal of molecular sciences · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Claudia PetrilloDepartment of Biology, Federico II University complesso universitario di Monte Sant' Angelo via Cinthia, 80126, Napoli, Italy.
Stefany CastaldiDepartment of Biology, Federico II University complesso universitario di Monte Sant' Angelo via Cinthia, 80126, Napoli, Italy.
Mariamichela LanzilliDepartment of Biology, Federico II University complesso universitario di Monte Sant' Angelo via Cinthia, 80126, Napoli, Italy.
Anella SaggeseDepartment of Biology, Federico II University complesso universitario di Monte Sant' Angelo via Cinthia, 80126, Napoli, Italy.
Giuliana DonadioDepartment of Biology, Federico II University complesso universitario di Monte Sant' Angelo via Cinthia, 80126, Napoli, Italy.
Loredana BaccigalupiDepartment of Molecular Medicine and Medical Biotechnology, Federico II University of Naples, Napoli, Italy.
Ezio RiccaDepartment of Biology, Federico II University complesso universitario di Monte Sant' Angelo via Cinthia, 80126, Napoli, Italy. ericca@unina.it.ORCID http://orcid.org/0000-0002-7355-0332
Rachele IsticatoDepartment of Biology, Federico II University complesso universitario di Monte Sant' Angelo via Cinthia, 80126, Napoli, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBacterial spores displaying heterologous antigens or enzymes have long been proposed as mucosal vaccines, functionalized probiotics or biocatalysts. Two main strategies have been developed to display heterologous molecules on the surface of Bacillus subtilis spores: (i) a recombinant approach, based on the construction of a gene fusion between a gene coding for a coat protein (carrier) and DNA coding for the protein to be displayed, and (ii) a non-recombinant approach, based on the spontaneous and stable adsorption of heterologous molecules on the spore surface. Both systems have advantages and drawbacks and the selection of one or the other depends on the protein to be displayed and on the final use of the activated spore. It has been recently shown that B. subtilis builds structurally and functionally different spores when grown at different temperatures; based on this finding B. subtilis spores prepared at 25, 37 or 42 °C were compared for their efficiency in displaying various model proteins by either the recombinant or the non-recombinant approach.

resultsImmune- and fluorescence-based assays were used to analyze the display of several model proteins on spores prepared at 25, 37 or 42 °C. Recombinant spores displayed different amounts of the same fusion protein in response to the temperature of spore production. In spores simultaneously displaying two fusion proteins, each of them was differentially displayed at the various temperatures. The display by the non-recombinant approach was only modestly affected by the temperature of spore production, with spores prepared at 37 or 42 °C slightly more efficient than 25 °C spores in adsorbing at least some of the model proteins tested.

conclusionOur results indicate that the temperature of spore production allows control of the display of heterologous proteins on spores and, therefore, that the spore-display strategy can be optimized for the specific final use of the activated spores by selecting the display approach, the carrier protein and the temperature of spore production.

Indexed as

TemperatureAdsorptionBacillus subtilisBacterial ProteinsGreen Fluorescent ProteinsPeptide FragmentsRecombinant Fusion ProteinsSpores, BacterialTetanus ToxinBacterial ProteinsGreen Fluorescent ProteinsPeptide FragmentsRecombinant Fusion ProteinsTetanus Toxintetanus toxin fragment CBacillus subtilisDisplay platformMucosal vaccinesProbiotics

Identifiers

PMID33004043
PMCPMC7528486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.